# Combination Chemotherapy in Treating Men With Germ Cell Cancer

> **NCT00003643** · PHASE2,PHASE3 · UNKNOWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 498 (estimated)

## Conditions studied

- Extragonadal Germ Cell Tumor
- Teratoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **BIOLOGICAL:** filgrastim
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003643
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 498 (ESTIMATED)
- **Last updated:** 2012-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003643, "Combination Chemotherapy in Treating Men With Germ Cell Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00003643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*